Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by TheTruth1234on Jan 03, 2025 4:32pm
138 Views
Post# 36386771

RE:RE:RE:RE:have dots been connected yet, jd??

RE:RE:RE:RE:have dots been connected yet, jd??
InitiumMMXXIII wrote: Yeah, predictions of the future of Bioasis turned out to be difficult for everybody, zwerp. UBC, NRC, Janssen, Shire, Chiesi, Denali, MidaTech, Ladenburg Thalmann, XOMA, they all got it wrong. All the directors like Saltarelli, Radhakrishnan and Stagliano got it wrong, not to mention executives like Antalik, Hill, Orfali and others.

I am honoured to have been in the company of these heavyweights and the hundreds of resaerchers and business experts associated with them.

I wonder how many of them think they were wrong. My guess is that they place the blame squarely on management failures and that if Bioasis has put money into research and early phase trials that the outcome would be different.

Here's a question for you, zwerp, TT, anybody. Why did Chiesi quit? Did xB3 fail or was there something else?

jd



Why did Chiesi quit? Did xB3 fail or was there something else?


Because it xb3 did not work as they hoped.

Chiesi did not want to waste any more money on a technology that was useless. 
<< Previous
Bullboard Posts
Next >>